Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation
Irwin MR, et al • Biological Psychiatry
Key Finding
Sleep disturbance associated with elevated CRP (effect size 0.12) and IL-6 (effect size 0.20); long sleep duration associated with higher CRP (effect size 0.17)
Key Findings
- 1Sleep disturbance: CRP effect size 0.12, IL-6 effect size 0.20
- 2Long sleep >8h: CRP effect size 0.17, IL-6 effect size 0.11
- 3Short sleep <7h: minimal inflammatory effects
- 472 studies, N>50,000 participants
Original title: “Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation”
Plain English Summary
Meta-analysis of 72 studies with over 50,000 participants found that sleep disturbance and long sleep duration (>8 hours), but not short sleep duration, are associated with increased markers of systemic inflammation including CRP and IL-6.
In-Depth Analysis
Abstract
"Sleep disturbance and long sleep duration, but not short sleep duration, are associated with increases in markers of systemic inflammation."
Methods
- •Design: Systematic review and meta-analysis
- •Sample: 72 studies, >50,000 participants
- •Markers Assessed: CRP, IL-6, TNF-α
Key Results
Sleep Disturbance
- •Associated with elevated CRP (effect size 0.12)
- •Associated with elevated IL-6 (effect size 0.20)
- •No association with TNF-α
Sleep Duration
- •Short sleep (<7 hours): Minimal inflammatory effects
- •Long sleep (>8 hours): Associated with higher CRP (effect size 0.17) and IL-6 (effect size 0.11)
Experimental Sleep Deprivation
- •Neither acute nor prolonged sleep restriction significantly altered inflammatory markers
Conclusions
Disturbed sleep quality and excessive sleep duration represent behavioral risk factors for systemic inflammation, potentially contributing to inflammatory disease development and mortality risk.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
RelevantConventional clinical guidelines used by most doctors
Why it matters:
Supports sleep assessment in cardiovascular risk evaluation; chronic sleep problems linked to elevated CRP
Research Consensus
RelevantCurrent scientific understanding, often ahead of guidelines
Why it matters:
Demonstrates U-shaped relationship—both short and long sleep durations associated with higher CRP
Metabolic Optimization
RelevantProactive targets for optimal health, not just disease absence
Why it matters:
Critical for metabolic optimization: sleep quality as modifiable lever for CRP reduction alongside diet and exercise
Study Details
- Type
- Meta-Analysis
- Methodology
- Systematic review and meta-analysis of 72 studies; N > 50,000 participants; examined associations between sleep problems and inflammatory markers (CRP, IL-6, TNF-α)
Evidence Quality
Grade A - Large meta-analysis. Source: PMC4666828
Related Biomarkers
Calculate & Evaluate on Metabolicum
Original Source
DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.
Related Studies
Low-grade inflammation, diet composition and health: current research evidence and its translation
Minihane AM, et al • British Journal of Nutrition • 2015
An unresolved inflammatory response is likely involved from early stages of disease development; current fasting inflammatory markers represent an insensitive and highly variable index of tissue inflammation
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Emerging Risk Factors Collaboration • Lancet • 2010
Per 3-fold higher CRP: CHD HR 1.37 (1.27-1.48), ischaemic stroke HR 1.27 (1.15-1.40), vascular mortality HR 1.55 (1.37-1.76) after adjustment
Omega-3 Fatty Acids and Inflammatory Processes
Calder PC • Nutrients • 2010
Effective anti-inflammatory effects require >2g EPA+DHA daily; EPA-derived eicosanoids 10-100 fold less potent as inflammatory mediators; new steady-state reached within ~4 weeks